PICO Portalanswers from OpenAlex
Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis
PaperCitations, authors & open-access status
Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis is a paper indexed in PICO Portal from OpenAlex.
How many citations does Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis have?
PICO Portalcitation count
Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis has 105 citations in the OpenAlex counts PICO Portal stores.
When was Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis published?
PICO Portalyear
Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis has 2020 year in the PICO Portal index.
What is the open-access status of Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis?
PICO Portaloa status
Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis has gold oa status in the PICO Portal index.
What is the DOI of Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis?
PICO Portaldoi
The DOI for Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis is on the source record.
What is the PMID of Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis?
PICO Portalpmid
The PMID for Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis is on the source record.
What is the OpenAlex record for Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis?
PICO Portalopenalex
The OpenAlex for Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis is on the source record.